[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07127952":3,"trial-entities:NCT07127952":91,"trial-summary:NCT07127952":94},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":23,"primary_purpose":24,"phases":25,"enrollment_info":27,"interventions":30,"primary_outcomes":40,"secondary_outcomes":45,"sex":50,"minimum_age":51,"maximum_age":52,"healthy_volunteers":14,"eligibility_criteria":53,"std_ages":59,"locations":62,"central_contacts":84,"overall_officials":85,"references":89,"see_also_links":90},"NCT07127952","25-001900","Correlations of the Microvascular Abnormalities on NVC (Nail Fold Video Capillaroscopy) and GAVE (Gastric Antral Vascular Ectasia) as Seen on EGD","ENROLLING_BY_INVITATION","2026-12-31","2026-01","2026-01-29","2025-05-03","Mayo Clinic","OTHER",false,"The purpose of this research is to determine whether a procedure called capillaroscopy can help distinguish patients who are diagnosed with GAVE (gastric antral vascular ectasia) with an autoimmune disease versus idiopathic\u002Fother conditions based on EGD findings.","The primary aim of this study is to define the prevalence and findings (as per quantification) of nail fold video capillaroscopy abnormalities in patients with GAVE. The secondary aim is to compare the findings of NVC and clinical presentation in patients with GAVE.",[18],"Gastric Antral Vascular Ectasia",[20,21,22,18],"GAVE","G.A.V.E","Gastric Antral Vascular","INTERVENTIONAL","SUPPORTIVE_CARE",[26],"NA",{"count":28,"type":29},75,"ESTIMATED",[31],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":38},"DEVICE","Video Capillaroscopy","A non-invasive imaging technique used to assess capillary structure and morphology in the nailfold area, commonly used in evaluating microvascular changes associated with connective tissue diseases.",[36,37],"GAVE with CTD","GAVE without connective tissue disease",[39],"Nailfold Video Capillaroscopy",[41],{"measure":42,"description":43,"timeFrame":44},"Prevalence and Phenotypic with G.A.V.E","Defined the prevalence and phenotype of nail fold video capillaroscopy abnormalities in patients with G.A.V.E.","From enrollment to end of study once the accrual has been met within baseline of Day 1",[46],{"measure":47,"description":48,"timeFrame":49},"Comparing Findings","To compare the findings of and VC and clinical manifestation and organ involvement patients with gave and connective tissue disease to those with gave without connective tissue disease.","From enrollment to end of study once the accrual has been met within baseline of day 1","ALL","18 Years","95 Years",{"inclusion":54,"exclusion":56,"raw_text":58},[55],"Patients 18 years and older with gave diagnosis as pair EGD performed in Gastroenterology as standard of care.",[57],"Age less than 18 years of age, pregnant individuals, dialysis dependent, type 2 diabetes, recent hand trauma or manicure (\\\u003C2 weeks), routine use of vibratory tools, history of acrocyanosis or erythromelalgia, previous diagnosis of a bleeding disorder, diagnosis of psoriasis, diagnosis of anti-phospholipid syndrome, exposure to toluene or benzoyl, diagnosis of psoriasis, diagnosis of COPD.","Inclusion Criteria:\n\n* Patients 18 years and older with gave diagnosis as pair EGD performed in Gastroenterology as standard of care.\n\nPatients with GAVE with connective tissue disease will be compared to patients with GAVE without a connective tissue disease.\n\nExclusion Criteria:\n\n* Age less than 18 years of age, pregnant individuals, dialysis dependent, type 2 diabetes, recent hand trauma or manicure (\\\u003C2 weeks), routine use of vibratory tools, history of acrocyanosis or erythromelalgia, previous diagnosis of a bleeding disorder, diagnosis of psoriasis, diagnosis of anti-phospholipid syndrome, exposure to toluene or benzoyl, diagnosis of psoriasis, diagnosis of COPD.",[60,61],"ADULT","OLDER_ADULT",[63,72,80],{"facility":64,"city":65,"state":66,"zip":67,"country":68,"geoPoint":69},"Mayo Clinic (Florida)","Jacksonville","Florida","32224","United States",{"lat":70,"lon":71},30.33218,-81.65565,{"facility":73,"city":74,"state":75,"zip":76,"country":68,"geoPoint":77},"Mayo Clinic Health System-Eau Claire Clinic","Eau Claire","Wisconsin","54701",{"lat":78,"lon":79},44.81135,-91.49849,{"facility":81,"city":74,"state":75,"zip":82,"country":68,"geoPoint":83},"Mayo Clinic Health Systems","54703-5211",{"lat":78,"lon":79},[],[86],{"name":87,"affiliation":12,"role":88},"Florentina Berianu, M.D.","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":92,"biomarkers":93},[18],[],{"nct_id":4,"found":14,"summary":95,"prompt_version":95},null]